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doi: 10.5694/mja15.00139ResearchRheumatic heart disease in Indigenous children in
northern Australia: differences in prevalence and
the challenges of screeningates of acute rheumatic fever Abstract
(ARF) and its sequel, rheu-Objectives: To compare regional differences in the prevalence of rheumatic
heart disease (RHD) detected by echocardiographic screening in high-risk
Indigenous Australian children, and to describe the logistical and other
practical challenges of RHD screening.
Design: Cross-sectional screening survey performed between September
2008 and November 2010.
Setting: Thirty-two remote communities in four regions of northern and
central Australia.
Participants: 3946 Aboriginal or Torres Strait Islander children aged
5e15 years.
Intervention: Portable echocardiography was performed by cardiac
sonographers. Echocardiograms were recorded and reported offsite by a
pool of cardiologists.
Main outcome measures: RHD was diagnosed according to 2012 World
Heart Federation criteria.
Results: The prevalence of deﬁnite RHD differed between regions,
from 4.7/1000 in Far North Queensland to 15.0/1000 in the Top End of
the Northern Territory. The prevalence of deﬁnite RHD was greater in the
Top End than in other regions (odds ratio, 2.3; 95% CI, 1.2e4.6, P ¼ 0.01).
Fifty-three per cent of detected cases of deﬁnite RHD were new cases; the
prevalence of new cases of deﬁnite RHD was 4.6/1000 for the entire
sample and 7.0/1000 in the Top End. Evaluation of socioeconomic data
suggests that the Top End group was the most disadvantaged in our study
population.
Conclusions: The prevalence of deﬁnite RHD in remote Indigenous
Australian children is signiﬁcant, with a substantial level of undetected
disease. Important differences were noted between regions, with the Top
End having the highest prevalence of deﬁnite RHD, perhaps explained by
socioeconomic factors. Regional differences must be considered when
evaluating the potential beneﬁt of widespread echocardiographic screening
in Australia.Rmatic heart disease (RHD) are
high in Indigenous Australians
(Aboriginal Australians or Torres
Strait Islander peoples).1,2 Estimates
of RHD prevalence have relied on
register data collected for clinical
purposes or on intermittent enhanced
surveillance projects,3 and have sug-
gested that 1%e2% of Indigenous
Australians living in northern and
central Australia have RHD.
Screening for RHD provides an op-
portunity to accurately deﬁne the
current disease burden, as well as to
identify children with undiagnosed
disease who may beneﬁt from early
treatment. A number of studies
have shown that cardiac auscultation
lacks the sensitivity and speciﬁcity
required for screening for RHD and
should no longer be used for this
purpose.4e6 Portable echocardiogra-
phy has emerged as a more valuable
tool, and its usefulnesswas enhanced
by the publication of theWorldHeart
Federation (WHF) criteria for the
echocardiographic diagnosis of RHD
in 2012 (Box 1).7
We recently published the results
of an echocardiographic screening
study of more than 5000 school-aged
children, including nearly 4000 In-
digenous children living in four
regions of northern and central
Australia.8 We used the WHF criteria
to compare the echocardiographic
ﬁndings of children at high and low
risk of RHD (as deﬁned by the RHD
Australia guidelines9). We found that
the overall prevalence of deﬁnite
RHD inhigh-risk Indigenous children
(8.6 per 1000) was comparable with
previous register-based estimates
from the Northern Territory. Deﬁnite
RHD was not identiﬁed in any low-
risk non-Indigenous children.
This study is methodologically the
most rigorous exploration of echocar-
diographic screening yet conducted,and the ﬁrst cross-sectional survey of
the prevalence of RHD in Australia.
However, we did not report the data
in sufﬁcient detail to maximise its
relevance for local RHD control in
Australia. In this article, we describe
the prevalence of deﬁnite and
borderline RHD in Indigenous chil-
dren from the Top End of the NT,
Central Australia, Far North Queens-
land (FNQ), including the Torres
Strait, and the Kimberley region of
Western Australia. By comparing the
ﬁndings in different regions and
describing some of the challenges of
the screening process, we aim to
inform decision making about the
potential impact and usefulness ofMJA 203 (5) jechocardiographic screening for RHD
in different Australian regions.
Methods
Design, setting and participants
The study design and population
and the sample size calculation have
been described previously.8 Brieﬂy,
we performed screening echocar-
diograms on 3946 Indigenous chil-
dren aged 5e15 years living in
remote communities in northern
Australia. Thirty-two communities
were selected from four geographical
regions (Box 2). Children were iden-
tiﬁed by the enrolment records of7 September 2015 221.e1
1 Echocardiographic criteria for rheumatic heart disease (RHD) in
individuals aged  20 years
Deﬁnite RHD (one of the following features):
 Pathological mitral regurgitation and at least two morphological features of
RHD of the mitral valve;
 Mitral stenosis mean gradient  4 mm Hg;*
 Pathological aortic regurgitation and at least twomorphological features of RHD
of the aortic valve;†
 Borderline disease of both the aortic valve and mitral valve.‡
Borderline RHD (one of the following features):
 At least two morphological features of RHD of the mitral valve without patho-
logical mitral regurgitation or mitral stenosis;
 Pathological mitral regurgitation;
 Pathological aortic regurgitation.
* Congenital mitral valve anomalies must be excluded. † Bicuspid aortic valve, dilated aortic root
and hypertension must be excluded. ‡ Combined aortic and mitral regurgitation in high prevalence
regions and in the absence of congenital heart disease is regarded as rheumatic. The four Doppler
echocardiographic criteria for pathological mitral regurgitation are that it be seen in two views; in at
least one view, jet length  2 cm; velocity  3 m/s for one complete envelope; and pan-systolic jet
in at least one envelope. The criteria for pathological aortic regurgitation are that it be seen in two
views; in at least one view, jet length  1 cm; velocity  3 m/s in early diastole; and pan-diastolic jet
in at least one envelope). Adapted from Remenyi et al.7u
2 Northern Australian sites where echocardiographic screening for
rheumatic heart disease was undertaken for this study
221.e2
Researchparticipating schools and were
recruited at school or by approaching
their families. Written informed
consent was obtained from parents
or guardians, and written consent
was also obtained from childrenwho
were at least 13 years old.
The study was conducted from
September 2008 to November 2010.
Ethics approval was obtained from
the Human Research Ethics Com-
mittee of the Northern Territory
Department of Health and Commu-
nity Services, the Central Australian
Human Research Ethics Committee,
the Cairns and Hinterland Health
Service District Human Research
Ethics Committee, the James Cook
University Human Ethics Commit-
tee, the University of Western
Australia Human Research Ethics
Committee, and the Western
Australian Aboriginal Health Infor-
mation and Ethics Committee.
Echocardiography protocol,
reporting and deﬁnitions
Screening echocardiograms were
performed by cardiac sonographers
according to an abbreviated protocol
that focused on the mitral and aortic
valves. Sonographers were provided
with a list of features that prompted
a more detailed, comprehensive
echocardiogram, also performed at
the time of screening, if required.
Screening echocardiograms were
recorded toDVDand reported offsite
by a pool of 14 cardiologists accord-
ing to our standardised electronic
protocol. These data were used post
hoc to determine whether children
met the WHF deﬁnitions of deﬁnite
or borderline RHD.
Clinical follow-up
Separate to reporting for research
purposes, all comprehensive echo-
cardiograms were sent to a local
cardiologist to guide clinical man-
agement of the participant. The
cardiologist provided a written
report that included the echocardio-
graphic ﬁndings and recommen-
dations for follow-up, including
secondary prophylaxis. Reportswere
sent to the primary health care team,
who used existing clinical services to
coordinate the necessary referrals.MJA 203 (5) j 7 September 2015Socioeconomic comparisons
We explored whether differences in
RHD prevalence between regions
could be attributed to socioeconomic
or demographic factors. No infor-
mation about socioeconomic factors
was collected from individual par-
ticipants. Instead, we used publicly
available statistics to compare the
socioeconomic characteristics of the
participating schools and commu-
nities. Information about school
attendance and the Indigenous status
of enrolled students, as well as Index
of Community Socio-EducationalAdvantage (ICSEA10) scores were
obtained for each participating
school from the Australian Govern-
ment’s MySchool website.11 The
ICSEA is a measure of the educa-
tional advantage of the students
enrolled at a particular school, based
on information about each student’s
family background (including pa-
rental occupation and level of edu-
cation). Themedian value of the scale
is 1000 with an SD of 100.
Information about household cro-
wding and Socio-Economic Indexes
Researchfor Areas (SEIFA12) scores were ob-
tained for each participating com-
munity from the Australian Bureau
of Statistics 2011 census data.13 Two
SEIFA scores were analysed: the In-
dex of Relative Social Disadvantage
(IRSD) and the Index of Relative So-
cial Advantage and Disadvantage
(IRSAD). These indices summarise
socioeconomic information about
the people and households in a
geographical area, and scales are
standardised with a mean value of
1000 and an SD of 100.
ICSEA, IRSD and IRSAD scores were
assigned to individuals according to
their school or community and to
calculate aggregate scores for each of
the four study regions.Statistical analysis
Statistical analysis was performed
with the Stata statistical package
(version 12.1; StataCorp).Descriptive
data are presented as medians and
interquartile range (IQR) for non-
normally distributed variables. Me-
dians were compared with the
ManneWhitney U test (for two
groups) or the KruskaleWallis test
(for more than two groups). Cate-
gorical variables were compared
with the c2 test. RHD prevalence
(with 95% CIs) was calculated for the
entire study sample and for each of3 Demographic characteristics of Ind
Characteristic
Top End
(n ¼ 100
Sex, n (%)
Male 497 (49.7
Female 503 (50.3
Ethnicity, n (%)
Aboriginal 998 (99.8
Torres Strait Islander 2 (0.2%
Aboriginal and Torres
Strait Islander
0
Comprehensive
echocardiogram
performed, n (%)
153 (15.3%
Age (years), median (IQR) 9.4 (7.4e1
Weight (kg), median (IQR) 26.5 (21.1e3
Height (cm), median (IQR) 133.0 (121.9e
BMI (kg/m2), median (IQR) 15.1 (14.0e1
BMI ¼ body mass index; IQR ¼ interquartile rangethe four regions. Multivariate logistic
regression was used to compare the
proportion of children with RHD in
each region. Socioeconomic variables
were comparedbymeansofANOVA
(IRSAD, IRSD and ICSEA) or
KruskaleWallis and ManneWhitney
U tests (household crowding).
Results
The demographic characteristics of
the 3946 remote Indigenous children
whohad a screening echocardiogram
are presented in Box 3. Forty-one per
cent of the FNQ participants were
identiﬁed as Torres Strait Islanders or
Aboriginal and Torres Strait Is-
landers, whereas more than 99% of
the other groups were identiﬁed as
Aboriginal only.
Despite the similar age and sex dis-
tribution of all four groups, children
from the Top End of the NT had a
signiﬁcantly lower median body
weight and body mass index than
children from the other three regions
(compared with Central Australia
and FNQ, P < 0.001; with the Kim-
berley, P ¼ 0.004; Box 3).
Of the 569 comprehensive echo-
cardiograms performed (13.3% of
children screened), signiﬁcantly
more were undertaken in FNQ
(17.2%) than in other jurisdictionsigenous children screened for rheuma
0)
Central Australia
(n ¼ 895)
Far North Que
(n ¼ 1265
%) 479 (53.5%) 641 (50.7%
%) 416 (46.5%) 624 (49.3
%) 892 (99.7%) 746 (59.0
) 2 (0.2%) 303 (24.0
1 (0.1%) 216 (17.1%
) 111 (12.4%) 217 (17.2%
1.6) 9.3 (7.3e11.3) 9.2 (7.2e11
5.5) 29.8 (22.9e40.8) 28.5 (21.8e3
147.0) 135.0 (123.0e149.0) 133.4 (120.1e
6.6) 16.2 (14.9e18.9) 16.2 (14.7e1
. * c2 test; † KruskaleWallis test.u(P < 0.001 compared with the Kim-
berley, P < 0.001; with Central
Australia, P ¼ 0.002; with the Top
End, P ¼ 0.26; Box 3). In the FNQ
group, more Torres Strait Islander
children (20.4%) required a compre-
hensive echocardiogram than did
non-Torres Strait Islander children
(14.9%, P < 0.001).
Prevalence of RHD based on
the WHF criteria
The prevalence of deﬁnite and
borderline RHD in each region is
presented in Box 4. The prevalence of
deﬁnite RHD was higher in Top End
children than in children from the
three other jurisdictions combined
(odds ratio [OR], 2.3; 95%CI, 1.2e4.6,
P ¼ 0.01). This difference was not
observed in the borderline RHD
category.
We have previously reported that 18
of the 34 children (52.9%) who met
the criteria for deﬁnite RHD were
new cases (no previous history of
ARF or RHD);8 the majority (93.9%)
of children meeting the criteria for
borderline RHDwere also new cases.
The prevalence of previously undi-
agnosed deﬁnite RHDdetected in the
entire study sample by screeningwas
4.6 per 1000 (95%CI, 2.7e7.2); for the
Top End, the prevalence of new cases
of deﬁnite RHD was 7.0 per 1000
(95% CI, 2.8e14.4).tic heart disease
ensland
)
Kimberley
(n ¼ 786) P
) 389 (49.5%) 0.30*
%) 397 (50.5%)
%) 786 (100.0%)
%) 0 < 0.001*
) 0
) 88 (11.2%) < 0.001*
.2) 9.3 (7.3e11.5) 0.15†
9.5) 27.4 (21.7e39.0) < 0.001†
145.8) 133.0 (121.4e148.2) 0.01†
9.0) 15.7 (14.4e17.9) < 0.001†
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4 Cases of rheumatic heart disease (RHD) in Indigenous children from four remote regions of northern
Australia
Top End
Central
Australia
Far North
Queensland Kimberley Total P (c2)
Deﬁnite RHD
New cases 7 4 5 2 18
Known cases 8 2 1 5 16 0.06
Prevalence 15.0/1000 6.7/1000 4.7/1000 8.9/1000 8.6/1000
95% CI 8.4e24.6 2.5e14.5 1.7e10.2 3.6e18.2 6.0e12.0
Borderline RHD
New cases 17 14 23 8 62
Known cases 1 1 2 0 4 0.41
Prevalence 18.0/1000 16.8/1000 19.8/1000 10.2/1000 16.7/1000
95% CI 10.7e28.3 9.4e27.5 12.8e29.0 4.4e20.0 13.0e21.2
Total screened 1000 895 1265 786 3946
221.e4
ResearchComparison of the
socioeconomic proﬁles of the
four regions
Thirty-eight schools from 32 com-
munities participated in the
screening study. Mean and median
ICSEA, IRSD and IRSAD scores for
each region are presented in Box 5.
The Top End communities had
signiﬁcantly lower mean ICSEA,
IRSD and IRSAD scores (ANOVA),
and signiﬁcantly higher levels of
household crowding (Kruskale
Wallis, ManneWhitneyU tests) than
the other regions (P < 0.05 for all
comparisons; Top End versus other
regions combined or individually).
Top End schools also had signiﬁ-
cantly lower median ICSEA scores
than the other regions combined and
each of Central Australia and FNQ
(for each comparison, P < 0.001), but
not when compared with Kimberley
schools (P ¼ 0.43).
Discussion
This is the ﬁrst prospective screening
survey for RHD in Indigenous
Australian children, and the ﬁrst
study to provide reliable information
about the epidemiology of RHD in
children from FNQ and the Kimber-
ley region of Western Australia. Our
previous report conﬁrmed that the
prevalence of RHD is high in Indig-
enous children, and that the overall
prevalence of deﬁnite RHD in
school-aged children (8.6 per 1000) isMJA 203 (5) j 7 September 2015comparable with ﬁgures from
developing countries.14e18 Although
this ﬁgure is similar to previous es-
timates of the prevalence of RHD in
the NT,1,2,19 there are important dif-
ferences between the four regions
when examined individually.
The most striking difference is the
higher prevalence of deﬁnite RHD in
children from the Top End of the NT.
The prevalence of 15.0 per 1000 is two
to three times higher than in other
regions, and nearly triple the previ-
ously published estimates of RHD
prevalence in Top End children (5.8
per 100020). Two more recent audits
of the NT register have been under-
taken, but only the combined data
from the Top End and Central
Australia have been published,1,19
reporting an RHD prevalence of 8.5
per 1000 in Indigenous children aged
5e14 years in the NT. Our study
suggests that this signiﬁcantly un-
derestimates the burden of disease in
the Top End, and that disease epide-
miology may be different in the Top
End and Central Australia.
This difference has not previously
been reported, and reasons for a
higher disease burden in the Top End
are not clear.However, some features
of our study sample may be relevant.
Wenoted that the growthparameters
of Top End children were signiﬁ-
cantly lower than those of children in
the other regions, and that the
participating Top End communitieshad the highest number of people per
household, a mean of 6.3 persons,
compared with the Australian
average of 2.6 persons per house-
hold.12 In addition, the ICSEA, ISRD
and IRSADscoreswere also lowest in
our Top End sample, between three
and ﬁve SDs below the Australian
average. It was striking how far
below the Australian mean these
scores were in all regions, high-
lighting the extreme disadvantage
experienced in remote Aboriginal
communities. We attempted to
quantify the relationship between
deﬁnite RHD and the four socioeco-
nomic measures by logistic regres-
sion, but the small number of cases of
deﬁnite RHD prevented this.
These observations suggest that the
participating communities from the
Top End were the most disadvan-
taged of the remote Indigenous
communities we surveyed. Given
that poverty-related factors, such as
overcrowded housing, are known to
be signiﬁcant risk factors forARFand
RHD,21e23 extreme disadvantage
would provide a plausible explana-
tion for the higher prevalence of RHD
in the Top End. Other possibilities
include inherent differences in host
susceptibility or in circulating strains
of group A Streptococcus (GAS), but
data are not available for the four
sampled regions to explore these
hypotheses. One NT study that
investigated the diversity of GAS
strains in the NT did not ﬁnd
5 Comparison of the socioeconomic characteristics of the four screening regions
Top End Central Australia
Far North
Queensland Kimberley
Number of Indigenous children aged 5e14 years
who were screened
1000 895 1265 786
Number of participating communities 7 10 7 8
Number of participating schools 7 14 8 9
Estimated number of Indigenous students enrolled
in participating schools (all ages)*
1765 1744 2635 1250
Estimated percentage of enrolled Indigenous
students who were screened
56.7% 51.3% 48.0% 62.9%
Average school attendance in participating
schools11
65.0% 68.0% 79.0% 67.0%
ICSEA score of participating schools11
Mean (SD) 576 (38) 643 (79) 622 (80) 583 (48)
Median (IQR) 569 (556e590) 631 (566e712) 587 (581e592) 567 (557e612)
IRSAD score of participating communities12
Mean (SD) 631 (67) 734 (96)† 759 (180) 711 (28)
Median (IQR) 688 (580e690) 695 (655e831) 678 (644e913) 694 (694e758)
IRSD score of participating communities12
Mean (SD) 533 (104) 676 (122)† 712 (224) 650 (33)
Median (IQR) 606 (443e641) 618 (570e795) 621 (585e903) 628 (628e704)
Number of people per household in participating
communities12
Mean (SD) 6.3 (0.9) 4.8 (1.1)† 4.5 (0.5) 4.8 (0.7)
Median (IQR) 6.8 (5.1e7.0) 5.0 (4.1e5.9) 4.2 (4.0e5.0) 4.6 (4.3e5.6)
ICSEA ¼ Index of Community Socio-Educational advantage; IRSAD ¼ Index of Relative Social Advantage and Disadvantage; IRSD ¼ Index of Relative
Social Disadvantage; IQR ¼ interquartile range. * The estimated number of Indigenous students per participating school was calculated from the total
school enrolment data (all ages) and the percentage of Indigenous students published on the MySchool website.11 † Alice Springs data excluded
because the signiﬁcant non-Indigenous residential population limits their usefulness.u
Research“NT-endemic” strains, and the au-
thors concluded that the high burden
of GAS disease was more probably
related to poor living conditions than
to bacterial factors.24
Selection bias may also contribute to
the observed differences in RHD
prevalence. Given the logistical
challenges of surveying a large
number of Indigenous children in
remote areas, we were unable to
select communities at random. We
instead carefully selected commu-
nities of different sizes and from
different areas in the samegeographic
region to provide as broad a sample
as possible (Box 2).
Only about 50% of school-enrolled
children were screened in our study
(although the percentages in Box 5
are slight underestimates, because
the school enrolment record includes
children of all ages, some of whom
were not eligible for our study).Given that the average daily atten-
dance in participating schools was
69%, this result is understandable,
and indicates our efforts to maximise
recruitment.
Whether the children we screened
were representative of all children in
the participating communities is an
important question. We were unable
to collect information about children
who had not consented to the study,
but Box 3 shows that there were no
differences in the sex or age distri-
butions of the samples from each re-
gion. It is probable that these ﬁgures
(equal sex and normal age distribu-
tions) are representative of the com-
munities as a whole, and that
selection bias is unlikely to explain
the observed differences in RHD
prevalence.
However, selection bias may have
resulted in an overall underestima-
tion of RHD prevalence. A school-based approach to screening is
practical, but potentially excludes
those most at risk of disease, such as
children who are too sick to attend
school, or who live in the most mar-
ginalised families. This may have
resulted in underestimation of the
full burden of RHD in remote Indig-
enous communities.
The number of new cases detected is
a crucial element in evaluating the
usefulness of any screening program.
More than half of the children
meeting the criteria for deﬁnite RHD
were new cases (Box 4), with an
overall prevalence of 4.6 new cases
per 1000 children screened. This
ﬁgure was substantially higher in the
Top End cohort, and our results
suggest that for every 1000 Top End
children screened, 7 new cases of
deﬁnite RHD would be detected,
equivalent to about 50 new cases in
this population. This information isMJA 203 (5) j 7 September 2015 221.e5
221.e6
Researchcritical for evaluating the cost-
effectiveness of screening, and we
are currently analysing the data.
We encountered a number of prac-
tical difﬁculties that have implica-
tions for future echocardiographic
screening in remote Australia. The
logistical challenges of travel to
remote communities are clear; travel
by road is slow and sometimes
impossible, and travel by plane is
expensive, requiring chartered ﬂights
to isolated areas not served by com-
mercial ﬂights. After staff had arrived
in the communities, the biggest chal-
lenge was ﬁnding and obtaining
consent from the children to be
screened, as school attendance was
poor.We tried to include absentees by
extending our screening activities
beyond the school grounds, which
was time-consuming and inefﬁcient.
Themost signiﬁcant challenges faced
by this study related to clinical
follow-up and communication with
families and health care providers. A
total of 569 children (14.4%, Box 3)
had comprehensive echocardio-
grams that required timely review by
an offsite cardiologist to guide clin-
ical management. This considerably
increased the workload of local car-
diologists, and it frequently took
weeks to months for reports to be
completed. Once available, the re-
ports themselves often generated
confusion and frustration for health
care providers, as illustrated by a
qualitative survey of health care
providers in three participating
screening sites.25 The WHF diag-
nostic criteria had not yet been pub-
lished when our study commenced,
so there was uncertainty about the
signiﬁcance of minor echocardio-
graphic changes in an otherwise
healthy child. This resulted in manyMJA 203 (5) j 7 September 2015paediatric cardiology referrals,
which often challenged the capacity
of local services.25 If echocardio-
graphic screening is to become
feasible as a routine approach, a
technical aspect that must be reﬁned
is thus to reduce the number of
comprehensive echocardiograms
that require review by a cardiologist.
Ensuring that health systems are
equipped to deal with the additional
increase in case numbers is vital
before initiating routine screening
activity.26
The impact of screening on the fam-
ilies of 68 children in our study was
explored by Wark and colleagues
with a Quality of Life (QOL) ques-
tionnaire.25 Although there was no
difference in the overall QOL sum-
mary scores, carers of children with
possibly abnormal echocardiograms
had poorer QOL scores in subscales
pertaining to general health percep-
tion and parental emotional impact.
In contrast, a study by a New Zea-
land group27 surveyed 114 families
who had participated in a more
recent school-based echocardio-
graphic screening program, and
found unanimous support for the
program. The authors concluded that
the screening process had no nega-
tive effects, norwere there short-term
adverse effects in the families of
children with abnormal results, in
terms of either health perception or of
parental anxiety.
The timing of the two studies and
methodological differences may ex-
plain these contrasting ﬁndings. In
the New Zealand study, screening
and reporting occurred within a
much shorter time period, and clin-
ical follow-up was performed by cli-
nicianswhowere directly involved in
the research process. In addition, theWHF criteria had been published
before the study commenced, re-
ducing diagnostic uncertainty re-
garding the signiﬁcance of minor
echocardiographic abnormalities and
facilitating appropriate clinical
follow-up.
In summary, our study identiﬁed a
previously unrecognised difference
in the prevalence of RHD in four
remote regions of northern Australia.
The prevalence of deﬁnite RHD in
Top End childrenwas nearly twice as
high as that in the other three regions,
and this may be related to socioeco-
nomic factors. We estimate that 4e8
per 1000 Indigenous children in
remote communities have unde-
tected RHD that could be identiﬁed
by echocardiographic screening.
Whether such screening should be
recommended will require further
and careful consideration of its cost-
effectiveness, feasibility, sustainabil-
ity and impact on primary and
specialist health care services. We are
currently preparing a cost-
effectiveness analysis that will allow
us to make informed recommenda-
tions regarding RHD screening to
national policymakers.
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